Xiamen Amoytop Biotech Co., Ltd. (688278.SS) SHH

Currency In CNY

AD

Valuation

Market Cap34.05B
Enterprise Value33.68B
P/E Ratio23.44
PEG Ratio1.76
Price/Sales Ratio6.28
Price/Book Ratio8.11
Enterprise/Revenue6.26
Enterprise/EBITDA18.95

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.27
Operating Margin0.33
AD

Management Effectiveness

Return On Assets0.24
Return On Equity0.33

Income Statement

Revenue3.7B
Revenue/Share9.89
Gross Profit3.44B
EBITDA1.24B
Net Income1.03B
Diluted EPS2.52

Balance Sheet

Total Cash947.98M
Total Cash/Share2.33
Total Debt769.53M
Total Debt/Equity0.25
Current Ratio4.73
Book Value Per Share7.73

Price History

52-Week Change-27.46
52-Week High89.65
52-Week Low50
Moving Average 50 Days57.76
Moving Average 200 Days67.24

Statistics

Average Volume4.4M
Shares Outstanding408.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield1
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD